Loss function of tumor suppressor FRMD8 confers resistance to tamoxifen therapy via a dual mechanism
W. Wu, M. Yu, Q. Li, Y. Zhao, L. Zhang, Y. Sun, Z. Wang, Y. Gong, W. Wang, C. Liu, J. Zhang, Y. Tang, X. Xu, X. Guo, J. Zhan, H. Zhang
This study identifies FRMD8 as a regulator of ER levels in ER-positive breast cancer, showing it confers tamoxifen resistance through dual mechanisms involving transcriptional and post-translational regulation of ER.
eLife · Apr 11, 2025Peer-reviewedCancer Biology